STATEN BIOTECHNOLOGY B V has a total of 31 patent applications. It increased the IP activity by 133.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are ARGENX BVBA, TODARO GEORGE JOSEPH and IMCHECK THERAPEUTICS SAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | China | 3 | |
#6 | Republic of Korea | 3 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Brazil | 1 | |
#9 | Chile | 1 | |
#10 | Colombia | 1 | |
#11 | Israel | 1 | |
#12 | Peru | 1 | |
#13 | Philippines | 1 | |
#14 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | De Haard Hans | 29 |
#2 | Dasilva-Jardine Paul | 26 |
#3 | Landro James A | 7 |
#4 | Dasilva Jardine Paul | 3 |
#5 | Paul Dasilva-Jardine | 1 |
#6 | Hans De Haard | 1 |
Publication | Filing date | Title |
---|---|---|
CA3113575A1 | Antibodies specific for human and cynomolgus apoc3 and methods of use thereof | |
US2019135906A1 | Anti-APOC3 antibodies and compositions thereof | |
CA3080103A1 | Anti-apoc3 antibodies and methods of use thereof | |
AU2018255938A1 | Anti-ApoC3 antibodies and methods of use thereof | |
CA3030099A1 | Anti-apoc3 antibodies and methods of use thereof |